Lexeo Therapeutics, Inc. /
Mantle Therapeutics Inc.
Lexeo Therapeutics, Inc. signed an agreement for Mantle Therapeutics Inc.
Source for the buyer and target: Lexeo Therapeutics, Inc.
For the buyer and target.
“On September 16, 2026, Lexeo Therapeutics, Inc. (“ Lexeo ” or the “ Company ”) entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Mantle Therapeutics Inc. (“ Mantle ”), Magma Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“ Merger Sub ”), and Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as representative, agent and attorney in fact of the Sellers.”
Published 22 Sep 2026
Open the sourceWhat happened
The deal for Mantle Therapeutics Inc. is signed, with Lexeo Therapeutics, Inc. as the buyer, at a stated price of $5,300,000 in cash, subject to certain adjustments; and (ii) $3,000,000 in shares of Lexeo common stock. [01]
The filing from Lexeo Therapeutics, Inc. is dated Sept. 22, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Lexeo Therapeutics, Inc. signed an agreement for Mantle Therapeutics Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly